Ex-Genzyme chief's $10M gift kicks off MGH cancer center

Tools

Biotech pioneer Henri Termeer (photo) can now add a startup to his resume. After recently retiring from Genzyme in the wake of the big Sanofi ($SNY) buyout, Termeer is seeding the Henri and Belinda Termeer Center for Targeted Therapies at Massachusetts General Hospital with a $10 million donation. Report

Filed Under